We are developing medications
to treat
substance abuse

Image

About Us

We enhance the development of first-in-class medicines to improve treatment of mental health disorders by propelling innovations from the lab into safe, affordable, and effective medicines for our patients.

Image
Image

Our Products

First-in-class medications to treat psychostimulant addictions.

Image Learn More
0.4
million Americans addicted to cocaine and methamphetamine
1
billion dollars in lost productivity due to substance abuse
0
billion dollar substance abuse medication market
0
FDA approved treatments for cocaine/methamphetamine

Our Team

 

Image

Aaron Lazarus

Chief Executive Officer

Image

Omeed Rahimi, Ph.D.

Chief Scientific Officer

Image

Steven Childers, Ph.D.

Chief Research Officer

  • Aaron Lazarus

    Aaron Lazarus

    Chief Executive Officer

    Our Chief Executive Officer manages all business operations and provides a vision for the future of EncepHeal Therapeutics, Inc. Lazarus previously served as project manager for the lead generation program at PatientStar LLC. He graduated from Wake Forest University with his M.A. in Management in 2015 and his B.S. in Biology in 2014.

  • Omeed Rahimi

    Omeed Rahimi, PhD

    Chief Scientific Officer

    ​As Chief Scientific Officer, Dr. Rahimi oversees the scientific development of each asset and is in charge of identifying new discoveries and technologies for incorporation into our business. Dr. Rahimi earned a B.S. in Biochemistry from the University of St. Thomas, a M.Sc. in Pharmacology from the University of Minnesota, and a Ph.D. in Integrative Physiology and Pharmacology from Wake Forest School of Medicine. His thesis research concentration focused on a potential therapy for the mitigation of chemotherapeutic cardiotoxicity.

  • Steven R Childers

    Steven R Childers

    Chief Research Officer

    ​As Chief Research Officer, Dr. Childers will lead the development of EncepHeal Therapeutics psychostimulant addiction therapeutics. With over 30+ years of experience he is widely regarded as a top expert in the field of biochemical neuropharmacology. Since 1999 his research has had a focus on the identification of potential medications to treat cocaine addiction. As part of that effort, his laboratory has screened over 600 novel compounds at brain target receptors to identify logical candidates for medication development.

Our Team

 

  • Aaron Lazarus

    Aaron Lazarus

    Chief Executive Officer

  • Aaron Lazarus

    Aaron Lazarus

  • Placeholder

Contact Us

Image

EncepHeal Therapeutics, Inc. 486 N Patterson Ave., Suite 204, Winston-Salem, NC 27101, USA